FDA.reportPublic FDA data

DuSel Psoriasis Dead Sea Salt Therapy

Manufacturer
Nanovita One LLC
Effective date
2017-02-07
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-02 01:20:11

Label at a glance#

ProductDuSel Psoriasis Dead Sea Salt Therapy
Active ingredientSALICYLIC ACID
Label structure6 sections

Indications and uses

For relief or controls the symptoms of psoriasis.

Dosage and administration

Cleanse the skin thoroughly before applying medication Cover the entire affected area with athin layer one to three times a day.Because excessive drying of the skinmay occur, start with one applicationdaily, then gradually increase to 2 to 3times daily if needed or as directed bya doctor. If bothersome dryness orpeeling occurs, reduce application toonce a day or every other day.

Label contents#

Full prescribing information#

Active Ingredient:

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2.00%

OTC - PURPOSE SECTION

Psoriasis treatment

Uses:

INDICATIONS & USAGE SECTION

For relief or controls the symptoms of psoriasis.

Warnings:

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  •  if you have very sensitive skin or are sensitive to Salicylic Acid

When using this product

OTC - WHEN USING SECTION

  •  Avoid contact with eyes. If this happens, rinse thoroughly with water.
  •  If conditions worsens or does not improve after regular use of this product as directed, consult a physician.
  • Use caution in exposing skin to sunlight after applying this product. It may increase your tendency to sunburn for up to 24 hours after application.
  •  If condition covers a large area of the body, consult your physician before using this product. Stop and ask a doctor if irritation becomes

Stop and ask a doctor if

OTC - STOP USE SECTION

irritation becomes severe

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Cleanse the skin thoroughly before applying medication
  • Cover the entire affected area with athin layer one to three times a day.Because excessive drying of the skinmay occur, start with one applicationdaily, then gradually increase to 2 to 3times daily if needed or as directed bya doctor. If bothersome dryness orpeeling occurs, reduce application toonce a day or every other day.

Inactive ingredients:

INACTIVE INGREDIENT SECTION

Aqua (Deionized Water), Cetearyl Olivate, Cetyl Alcohol, Ethylhexylglycerin, Helianthus Annuus (Sunflower) Oil, C13-14 Isoparaffin, Isopropyl
Myristate, Laureth-7, Maris Sal (Dead Sea) Salt, Phenoxyethanol, Polyacrylamide, Sorbitan Olivate, Stearic Acid, Tocopheryl Acetate (Vitamin E), Xanthan Gum, Zemea (Corn) Propanediol.

Package Labeling:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Psoriasis 5mlPsoriasis 5ml

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70656-74070656-740-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
CETEARYL OLIVATE58B69Q84JOIACT
CETYL ALCOHOL936JST6JCNIACT
ETHYLHEXYLGLYCERIN147D247K3PIACT
HELIANTHUS ANNUUS FLOWERING TOPBKJ0J3D1BPIACT
C13-14 ISOPARAFFINE4F12ROE70IACT
ISOPROPYL MYRISTATE0RE8K4LNJSIACT
LAURETH-7Z95S6G8201IACT
PHENOXYETHANOLHIE492ZZ3TIACT
SORBITAN OLIVATEMDL271E3GRIACT
STEARIC ACID4ELV7Z65APIACT
.ALPHA.-TOCOPHEROL ACETATE9E8X80D2L0IACT
XANTHAN GUMTTV12P4NEEIACT
CORN0N8672707OIACT
SALICYLIC ACIDO414PZ4LPZACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0722e7dc-80e6-2a72-e063-6294a90a54307be4b782-e4cd-4e7b-b61e-bc23080fe1192023-10-07WarningsExact identifier
spl set id: 7be4b782-e4cd-4e7b-b61e-bc23080fe119

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.